Employees can often be the most effective antidote to pharma companies' reputation issues.
When AstraZeneca (AZ) last year restructured internal communications, the intention was to move from siloed tactical execution to having a more strategic alignment with the overall company.
And that was no small feat. The London-based pharmaceutical company has 12,000 US employees and 65,000 worldwide, and internal constituencies are function- ally and geographically diverse.
But it was a vital endeavor, nonetheless. Pharma companies have the twin pressures of reputation issues ...